BIO-TECHNE Corp — Director's Dealing 2017

Jul 11, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO-TECHNE Corp (TECH)
CIK: 0000842023
Period of Report: 2017-07-09

Reporting Person: Gould Kevin S (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-07-09	Common Stock	F	312.00	$117.68	Disposed	1355.00	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Restricted Stock Units	$		Common Stock (2111.00)	2111.00	Direct
Stock Options (Right to Buy)	$106.59	2023-08-18	Common Stock (17371.00)	17371.00	Direct
Stock Options (Right to Buy)	$106.59	2023-08-18	Common Stock (13028.00)	13028.00	Direct
Stock Options (Right to Buy)	$97.23	2022-07-09	Common Stock (50000.00)	50000.00	Direct
Stock Options (Right to Buy)	$97.23	2022-07-09	Common Stock (15000.00)	15000.00	Direct
Stock Options (Right to Buy)	$88.23	2023-01-04	Common Stock (10000.00)	10000.00	Direct

Footnotes

F1: Includes 834 shares of restricted stock units that vest on 7/9/18.

F2: Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.

F3: Vests in full or in part on 8/18/19 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).

F4: Vests 4,343 shares on each of 8/18/17, 8/18/18 and 8/18/19, and 4,342 shares on 8/18/20.

F5: 50,000 common stock options vest if certain performance goals are achieved for the 12 months ending 05/31/18.

F6: Vests as to 3,750 shares on each of 7/9/16, 7/9/17, 7/9/18 and 7/9/19.

F7: Vests as to 2,500 shares on each of 01/04/17, 01/04/18, 01/04/19 and 01/04/20.